Reinforcing Therapist Performance (RTP)
The specific aims of the proposed study are to evaluate the effectiveness and cost-effectiveness of providing monetary incentives to therapists as a method to improve implementation of evidence-based treatments.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
|Official Title:||Reinforcing Therapist Performance|
- Target A-CRA [ Time Frame: 14 weeks post intake ] [ Designated as safety issue: No ]Based on a review of recordings of actual client sessions is an indicator of whether or not clients received 10 or more of 12 specified treatment procedures within no less than seven treatment sessions.
- A-CRA Competence [ Time Frame: Monthly ] [ Designated as safety issue: No ]Based on review of a randomly selected session recording is an indicator of whether or not participants delivered at least one treatment procedure at or above the level of competence required as part of the certification process.
- Percent of days abstinent [ Time Frame: 6 months post-intake ] [ Designated as safety issue: No ]Based on client self report is the percentage of days during the past 90 days that clients reported not using any alcohol or other drugs.
- Pay-for-performance Cost-Effectiveness [ Time Frame: First six months of study ] [ Designated as safety issue: No ]The cost per unit of Target A-CRA, A-CRA Competene, and Percentage of Days Abstient in the experimental condition relative to the control condition.
|Study Start Date:||November 2008|
|Study Completion Date:||June 2011|
|Primary Completion Date:||June 2011 (Final data collection date for primary outcome measure)|
|No Intervention: Control|
Participants assigned to the experimental condition are reinforced via monetary incentives for demonstrating superior delivery of an evidence treatment to clients
Please refer to this study by its ClinicalTrials.gov identifier: NCT01016704
|United States, Illinois|
|Lighthouse Institute, Chestnut Health Systems|
|Normal, Illinois, United States, 61761|
|Principal Investigator:||Bryan R Garner, Ph.D.||Chestnut Health Systems|